{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:53:29Z","timestamp":1780340009402,"version":"3.54.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Baise Science Research and Technology Development Program","award":["Grant No.Baike 20250338"],"award-info":[{"award-number":["Grant No.Baike 20250338"]}]},{"name":"Beijing Medical AwardFoundation","award":["YXJL-2022-0665-0210"],"award-info":[{"award-number":["YXJL-2022-0665-0210"]}]},{"name":"Guangxi Key Researchand Development Program","award":["Grant No.GuikeAB23026087"],"award-info":[{"award-number":["Grant No.GuikeAB23026087"]}]},{"name":"Natural Science Foundation of GuangxiZhuangAutonomous Region","award":["Grant No.2023GXNSFAA026225"],"award-info":[{"award-number":["Grant No.2023GXNSFAA026225"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01828-5","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:23:54Z","timestamp":1752776634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrative habitat analysis and multi-instance deep learning for predictive model of PD-1\/PD-L1 immunotherapy efficacy in NSCLC patients: a dual-center retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoxiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Housheng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"issue":"9","key":"1828_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10183","key":"1828_CR2","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","volume":"393","author":"TSK Mok","year":"2019","unstructured":"Mok TSK, Wu YL, Kudaba I, Kowalski DM, Cho BC, Turna HZ, Castro G Jr., Srimuninnimit V, Laktionov KK, Bondarenko I, et al. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. Lancet. 2019;393(10183):1819\u201330.","journal-title":"Lancet"},{"issue":"10400","key":"1828_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(23)00774-2","volume":"402","author":"SM Lee","year":"2023","unstructured":"Lee SM, Schulz C, Prabhash K, Kowalski D, Szczesna A, Han BH, Rittmeyer A, Talbot T, Vicente D, Califano R, et al. First-line Atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. Lancet. 2023;402(10400):451\u201363.","journal-title":"Lancet"},{"issue":"7","key":"1828_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","volume":"20","author":"H West","year":"2019","unstructured":"West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T, et al. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20(7):924\u201337.","journal-title":"Lancet Oncol"},{"issue":"14","key":"1828_CR5","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, Reinmuth N, Vergnenegre A, Barrios CH, Morise M, Felip E, Andric Z, Geater S, et al. Atezolizumab for First-Line treatment of PD-L1-Selected patients with NSCLC. N Engl J Med. 2020;383(14):1328\u201339.","journal-title":"N Engl J Med"},{"issue":"4","key":"1828_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10147-022-02120-0","volume":"27","author":"T John","year":"2022","unstructured":"John T, Sakai H, Ikeda S, Cheng Y, Kasahara K, Sato Y, Nakahara Y, Takeda M, Kaneda H, Zhang HL, et al. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in checkmate 9LA. Int J Clin Oncol. 2022;27(4):695\u2013706.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"1828_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cll.2019.07.012","volume":"39","author":"JR Farmer","year":"2019","unstructured":"Farmer JR. Testing immune-related adverse events in cancer immunotherapy. Clin Lab Med. 2019;39(4):669.","journal-title":"Clin Lab Med"},{"issue":"2","key":"1828_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.alit.2022.01.001","volume":"71","author":"N Okiyama","year":"2022","unstructured":"Okiyama N, Tanaka R. Immune-related adverse events in various organs caused by immune checkpoint inhibitors. Allergol Int. 2022;71(2):169\u201378.","journal-title":"Allergol Int"},{"issue":"10027","key":"1828_CR9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, P\u00e9rez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540\u201350.","journal-title":"Lancet"},{"issue":"8","key":"1828_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jtho.2024.04.011","volume":"19","author":"SM Gadgeel","year":"2024","unstructured":"Gadgeel SM, Rodr\u00edguez-Abreu D, Halmos B, Garassino MC, Kurata T, Cheng Y, Jensen E, Shamoun M, Rajagopalan K, Paz-Ares L. Pembrolizumab plus chemotherapy for metastatic NSCLC with programmed cell death ligand 1 tumor proportion score less than 1%: pooled analysis of outcomes after five years of Follow-Up. J Thorac Oncol. 2024;19(8):1228\u201341.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"1828_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A, et al. Radiomics: the Bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"1828_CR12","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1007\/s00259-021-05242-1","volume":"48","author":"GY Wu","year":"2021","unstructured":"Wu GY, Jochems A, Refaee T, Ibrahim A, Yan CG, Sanduleanu S, Woodruff HC, Lambin P. Structural and functional radiomics for lung cancer. Eur J Nucl Med Mol Imaging. 2021;48(12):3961\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"1828_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1101\/cshperspect.a039537","volume":"11","author":"I Tunali","year":"2021","unstructured":"Tunali I, Gillies RJ, Schabath MB. Application of radiomics and artificial intelligence for lung Cancer precision medicine. Cold Spring Harb Perspect Med. 2021;11(8):24.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"1828_CR14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.21037\/tlcr-20-708","volume":"10","author":"F Binczyk","year":"2021","unstructured":"Binczyk F, Prazuch W, Bozek P, Polanska J. Radiomics and artificial intelligence in lung cancer screening. Transl Lung Cancer Res. 2021;10(2):1186\u201399.","journal-title":"Transl Lung Cancer Res"},{"key":"1828_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcancer.2023.05.004","volume":"93","author":"M Chen","year":"2023","unstructured":"Chen M, Copley SJ, Viola P, Lu HA, Aboagye EO. Radiomics and artificial intelligence for precision medicine in lung cancer treatment. Semin Cancer Biol. 2023;93:97\u2013113.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1828_CR16","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.7150\/thno.48027","volume":"11","author":"P Tian","year":"2021","unstructured":"Tian P, He B, Mu W, Liu K, Liu L, Zeng H, Liu Y, Jiang L, Zhou P, Huang Z, et al. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images. Theranostics. 2021;11(5):2098\u2013107.","journal-title":"Theranostics"},{"issue":"5","key":"1828_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1109\/TMI.2016.2536809","volume":"35","author":"AAA Setio","year":"2016","unstructured":"Setio AAA, Ciompi F, Litjens G, Gerke P, Jacobs C, van Riel SJ, Wille MMW, Naqibullah M, Sanchez CI, van Ginneken B. Pulmonary nodule detection in CT images: false positive reduction using Multi-View convolutional networks. IEEE Trans Med Imaging. 2016;35(5):1160\u20139.","journal-title":"IEEE Trans Med Imaging"},{"key":"1828_CR18","doi-asserted-by":"crossref","unstructured":"Wei JW, Tafe LJ, Linnik YA, Vaickus LJ, Tomita N, Hassanpour S. Pathologist-level classification of histologic patterns on resected lung adenocarcinoma slides with deep neural networks. Sci Rep. 2019;9(1):3358.","DOI":"10.1038\/s41598-019-40041-7"},{"issue":"9","key":"1828_CR19","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1007\/s00330-021-07794-0","volume":"31","author":"Y Yu","year":"2021","unstructured":"Yu Y, Wang N, Huang N, Liu X, Zheng Y, Fu Y, Li X, Wu H, Xu J, Cheng J. Determining the invasiveness of ground-glass nodules using a 3D multi-task network. Eur Radiol. 2021;31(9):7162\u201371.","journal-title":"Eur Radiol"},{"issue":"1","key":"1828_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10278-019-00223-1","volume":"33","author":"J Park","year":"2020","unstructured":"Park J, Yun J, Kim N, Park B, Cho Y, Park HJ, Song M, Lee M, Seo JB. Fully automated lung lobe segmentation in volumetric chest CT with 3D U-Net: validation with Intra- and Extra-Datasets. J Digit Imaging. 2020;33(1):221\u201330.","journal-title":"J Digit Imaging"},{"key":"1828_CR21","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liao Q, Ding L, Zhang J. Bridging 2D and 3D segmentation networks for computation efficient volumetric medical image segmentation: an empirical study of 2.5D solutions. arXiv. 2022.","DOI":"10.1016\/j.compmedimag.2022.102088"},{"key":"1828_CR22","doi-asserted-by":"crossref","unstructured":"Jenkin Suji R, Bhadauria SS, Wilfred Godfrey W. A survey and taxonomy of 2.5D approaches for lung segmentation and nodule detection in CT images. Comput Biol Med. 2023;165:107437.","DOI":"10.1016\/j.compbiomed.2023.107437"},{"key":"1828_CR23","doi-asserted-by":"crossref","unstructured":"Kim Y, Kim Y-G, Park JW, Kim BW, Shin Y, Kong SH, Kim JH, Lee Y-K, Kim SW, Shin CS. A CT-based deep learning model for predicting subsequent fracture risk in patients with hip fracture. Radiology. 2024;310(1).","DOI":"10.1148\/radiol.230614"},{"key":"1828_CR24","doi-asserted-by":"crossref","unstructured":"Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, et al. 2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data. Front Neuroinform. 2022;16:1056068.","DOI":"10.3389\/fninf.2022.1056068"},{"key":"1828_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.patcog.2017.10.009","volume":"77","author":"M-A Carbonneau","year":"2018","unstructured":"Carbonneau M-A, Cheplygina V, Granger E, Gagnon G. Multiple instance learning: A survey of problem characteristics and applications. Pattern Recogn. 2018;77:329\u201353.","journal-title":"Pattern Recogn"},{"key":"1828_CR26","doi-asserted-by":"crossref","unstructured":"Jin S, Xu H, Dong Y, Wang X, Hao X, Qin F, Wang R, Cong F. Ranking attention multiple instance learning for lymph node metastasis prediction on multicenter cervical cancer MRI. J Appl Clin Med Phys. 2024;25(12).","DOI":"10.1002\/acm2.14547"},{"key":"1828_CR27","doi-asserted-by":"crossref","unstructured":"Chang R, Qi S, Wu Y, Song Q, Yue Y, Zhang X, Guan Y, Qian W. Deep multiple instance learning for predicting chemotherapy response in non-small cell lung cancer using pretreatment CT images. Sci Rep. 2022;12(1).","DOI":"10.1038\/s41598-022-24278-3"},{"key":"1828_CR28","doi-asserted-by":"crossref","unstructured":"Qin F, Sun X, Tian M, Jin S, Yu J, Song J, Wen F, Xu H, Yu T, Dong Y. Prediction of lymph node metastasis in operable cervical cancer using clinical parameters and deep learning with MRI data: a multicentre study. Insights into Imaging. 2024;15(1).","DOI":"10.1186\/s13244-024-01618-7"},{"issue":"1","key":"1828_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1148\/radiol.13122697","volume":"269","author":"RA Gatenby","year":"2013","unstructured":"Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in Cancer evolution and ecology. Radiology. 2013;269(1):8\u201315.","journal-title":"Radiology"},{"issue":"5","key":"1828_CR30","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/jmri.24921","volume":"42","author":"B Chaudhury","year":"2015","unstructured":"Chaudhury B, Zhou M, Goldgof DB, Hall LO, Gatenby RA, Gillies RJ, Patel BK, Weinfurtner RJ, Drukteinis JS. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with Estrogen receptor status and nodal metastasis. J Magn Reson Imaging. 2015;42(5):1421\u201330.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1828_CR31","first-page":"12","volume":"308","author":"ZW Shi","year":"2023","unstructured":"Shi ZW, Huang XM, Cheng ZL, Xu Z, Lin H, Liu C, Chen XB, Liu CL, Liang CH, Lu C, et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast Cancer. Radiology. 2023;308(1):12.","journal-title":"Radiology"},{"key":"1828_CR32","doi-asserted-by":"crossref","unstructured":"Huang H, Chen H, Zheng D, Chen C, Wang Y, Xu L, Wang Y, He X, Yang Y, Li W. Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation. Cancer Imaging. 2024;24(1).","DOI":"10.1186\/s40644-024-00692-w"},{"key":"1828_CR33","doi-asserted-by":"crossref","unstructured":"Chen S, Zhang Y, Su Y, Tian J, Chen Y, Tang W, Fan Y, Jin C, He Y, Xu Y, et al. Habitat radiomics based on dynamic contrast-enhanced magnetic resonance imaging for assessing axillary lymph node burden in clinical T1-T2 stage breast cancer: a multicenter and interpretable study. J Magn Reson Imaging. 2025.","DOI":"10.1002\/jmri.29796"},{"key":"1828_CR34","doi-asserted-by":"crossref","unstructured":"Zhang H, Zheng Y, Zhang M, Wang A, Song Y, Wang C, et al. Breast cancer: habitat imaging based on intravoxel incoherent motion for predicting pathologic complete response to neoadjuvant chemotherapy. Med Phys. 2025;52(6):3711\u201322.","DOI":"10.1002\/mp.17813"},{"key":"1828_CR35","doi-asserted-by":"crossref","unstructured":"Wang Y, Xie B, Wang K, Zou W, Liu A, Xue Z, Liu M, Ma Y. Multi-parametric MRI habitat radiomics based on interpretable machine learning for preoperative assessment of microsatellite instability in rectal cancer. Acad Radiol. 2025.","DOI":"10.1016\/j.acra.2025.02.009"},{"issue":"12","key":"1828_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","volume":"14","author":"P Lambin","year":"2017","unstructured":"Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, et al. Radiomics: the Bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"1828_CR37","first-page":"11","volume":"11","author":"C Liu","year":"2021","unstructured":"Liu C, Gong J, Yu H, Liu Q, Wang SP, Wang JL. A CT-based radiomics approach to predict nivolumab response in advanced non-small-cell lung cancer. Front Oncol. 2021;11:11.","journal-title":"Front Oncol"},{"issue":"10","key":"1828_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jitc-2023-007369","volume":"11","author":"SW Wu","year":"2023","unstructured":"Wu SW, Zhan WJ, Liu L, Xie DP, Yao LT, Yao HN, Liao GQ, Huang LY, Zhou YB, You PM, et al. Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study. J Immunother Cancer. 2023;11(10):15.","journal-title":"J Immunother Cancer"},{"key":"1828_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen F, Zhuang XQ, Lin LY, Yu PF, Wang Y, Shi YF, Hu GH, Sun Y. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med. 2015;13:13.","journal-title":"BMC Med"},{"issue":"11","key":"1828_CR40","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"2","key":"1828_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-018-4109-x","volume":"46","author":"J Kirchner","year":"2019","unstructured":"Kirchner J, Sawicki LM, Nensa F, Schaarschmidt BM, Reis H, Ingenwerth M, Bogner S, Aigner C, Buchbender C, Umutlu L, et al. Prospective comparison of 18F-FDG PET\/MRI and 18F-FDG PET\/CT for thoracic staging of non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2019;46(2):437\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1828_CR42","doi-asserted-by":"crossref","unstructured":"Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-Positive breast Cancer. Jama Netw Open. 2019;2(4).","DOI":"10.1001\/jamanetworkopen.2019.2561"},{"issue":"2","key":"1828_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JPB O\u2019Connor","year":"2015","unstructured":"O\u2019Connor JPB, Rose CJ, Waterton JC, Carano RAD, Parker GJM, Jackson A. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res. 2015;21(2):249\u201357.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1828_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40644-024-00692-w","volume":"24","author":"HZ Huang","year":"2024","unstructured":"Huang HZ, Chen H, Zheng DZ, Chen C, Wang Y, Xu LC, Wang YH, He XH, Yang YY, Li WT. Habitat-based radiomics analysis for evaluating immediate response in colorectal cancer lung metastases treated by radiofrequency ablation. Cancer Imaging. 2024;24(1):11.","journal-title":"Cancer Imaging"},{"issue":"2","key":"1828_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Vallieres M, Abdalah MA, Aerts HJWL, Andrearczyk V, Apte A, Ashrafinia S, Bakas S, Beukinga R, Boellaard R, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295(2):328\u201338.","journal-title":"Radiology"},{"issue":"10","key":"1828_CR46","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"1828_CR47","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1148\/rg.2021210037","volume":"41","author":"JD Shur","year":"2021","unstructured":"Shur JD, Doran SJ, Kumar S, ap Dafydd D, Downey K, O\u2019Connor JPB, Papanikolaou N, Messiou C, Koh D-M, Orton MR. Radiomics in oncology: A practical guide. Radiographics. 2021;41(6):1717\u201332.","journal-title":"Radiographics"},{"key":"1828_CR48","doi-asserted-by":"crossref","unstructured":"Ye G, Wu G, Zhang C, Wang M, Liu H, Song E, et al. CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer. Front Immunol. 2024;15:1414954.","DOI":"10.3389\/fimmu.2024.1414954"},{"issue":"3","key":"1828_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","volume":"14","author":"JPB O\u2019Connor","year":"2017","unstructured":"O\u2019Connor JPB, Aboagye EO, Adams JE, Aerts HJWL, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14(3):169\u201386.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1828_CR50","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278(2):563\u201377.","journal-title":"Radiology"},{"issue":"11","key":"1828_CR51","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1158\/1078-0432.CCR-18-2495","volume":"25","author":"Y Xu","year":"2019","unstructured":"Xu Y, Hosny A, Zeleznik R, Parmar C, Coroller T, Franco I, Mak RH, Aerts HJWL. Deep learning predicts lung Cancer treatment response from serial medical imaging. Clin Cancer Res. 2019;25(11):3266\u201375.","journal-title":"Clin Cancer Res"},{"key":"1828_CR52","doi-asserted-by":"crossref","unstructured":"Huang B, Sollee J, Luo YH, Reddy A, Zhong Z, Wu J, et al. Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET\/CT. EBioMedicine. 2022;82:104127.","DOI":"10.1016\/j.ebiom.2022.104127"},{"key":"1828_CR53","doi-asserted-by":"crossref","unstructured":"Mu W, Jiang L, Shi Y, Tunali I, Gray JE, Katsoulakis E, Tian J, Gillies RJ, Schabath MB. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET\/CT images. J Immunother Cancer. 2021;9(6).","DOI":"10.1136\/jitc-2020-002118"},{"key":"1828_CR54","doi-asserted-by":"crossref","unstructured":"Wang C, Ma J, Shao J, Zhang S, Li J, Yan J, et al. Non-invasive measurement using deep learning algorithm based on multi-source features fusion to predict PD-L1 expression and survival in NSCLC. Front Immunol. 2022;13:828560.","DOI":"10.3389\/fimmu.2022.828560"},{"issue":"3","key":"1828_CR55","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1109\/TPAMI.2020.3017456","volume":"44","author":"N Tam","year":"2022","unstructured":"Tam N, Raich R. Incomplete label multiple instance multiple label learning. IEEE Trans Pattern Anal Mach Intell. 2022;44(3):1320\u201337.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"5","key":"1828_CR56","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1002\/mp.15539","volume":"49","author":"J Chen","year":"2022","unstructured":"Chen J, Zeng H, Zhang C, Shi Z, Dekker A, Wee L, Bermejo I. Lung cancer diagnosis using deep attention-based multiple instance learning and radiomics. Med Phys. 2022;49(5):3134\u201343.","journal-title":"Med Phys"},{"issue":"6","key":"1828_CR57","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1007\/s00330-022-09337-7","volume":"33","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Chen M, Hu G, Pan Z, Han W, Tan W, Zhou Z, Wang M, Mao L, Li X, et al. A pre-treatment CT-based weighted radiomic approach combined with clinical characteristics to predict durable clinical benefits of immunotherapy in advanced lung cancer. Eur Radiol. 2023;33(6):3918\u201330.","journal-title":"Eur Radiol"},{"issue":"24","key":"1828_CR58","doi-asserted-by":"publisher","first-page":"11080","DOI":"10.7150\/thno.49864","volume":"10","author":"R Cao","year":"2020","unstructured":"Cao R, Yang F, Ma S-C, Liu L, Zhao Y, Li Y, Wu D-H, Wang T, Lu W-J, Cai W-J, et al. Development and interpretation of a pathomics-based model for the prediction of microsatellite instability in colorectal Cancer. Theranostics. 2020;10(24):11080\u201391.","journal-title":"Theranostics"},{"key":"1828_CR59","doi-asserted-by":"crossref","unstructured":"Caii W, Wu X, Guo K, Chen Y, Shi Y, Chen J. Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients. Cancer Immunol Immunother. 2024;73(8).","DOI":"10.1007\/s00262-024-03724-3"},{"issue":"2","key":"1828_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale I, Shema E, Loi S, Galluzzi L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med. 2021;27(2):212\u201324.","journal-title":"Nat Med"},{"key":"1828_CR61","doi-asserted-by":"crossref","unstructured":"Li Q, Huang X, Fang B, Zhang Y, Chen Y, Chen J. PnP-AE: a plug-and-play module for volumetric medical image segmentation. In: 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 2023:2059\u20132064.","DOI":"10.1109\/BIBM58861.2023.10385472"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01828-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:56:24Z","timestamp":1757253384000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01828-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01828-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Guangxi Medical University Cancer Hospital (identifier: KY-2022-301). The ethics committee waived the requirement for informed consent due to the retrospective nature of the study using anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}